NCT00964873 A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE1
NCT00961142 Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia Status TERMINATED Phase PHASE2
NCT00957320 Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) Status WITHDRAWN Phase PHASE1
NCT00954720 Observational Study of Iron Overload in Stem Cell Transplantation Status COMPLETED Phase N/A
NCT00945828 Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors Status COMPLETED Phase NA
NCT00944008 PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE3
NCT00940524 Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT00930098 A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia Status COMPLETED Phase PHASE2
NCT00911066 MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT00905398 Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT00902213 Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic Leukemia Status COMPLETED Phase NA
NCT00900445 Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia Status WITHDRAWN Phase N/A
NCT00890656 Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage Status COMPLETED Phase PHASE2
NCT00866307 Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) Status COMPLETED Phase PHASE1
NCT00866281 A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia Status TERMINATED Phase PHASE1/PHASE2